Conference Highlights 🤝 Regional Collaboration Forum 🤝 For the very first time, the Taiwan BIO collaborated with the Taiwan External Trade Development Council (TAITRA) to co-host the Regional Collaboration Forum, which Australia, Japan, Belgium, Thailand, India, and Malaysia also each host their own country-specific forum with a total of 40 companies participating to explore cross nation collaboration opportunities. During the Plenary Session, representatives from each country shared insights on their respective industries. Helen Dai, Trade and Investment Commissioner, Australia Trade and Investment Commission (Austrade), highlighted Australia's strengths in clinical trials, including the government's efficient approval process and favorable policies for talent and immigration, making Australia a top destination for clinical trials. Els Verhulst, Science & Technology Counselor, FLANDERS INVESTMENT & TRADE, Embassy of Belgium in Tokyo, Japan, noted that Belgium is a major powerhouse in life sciences and pharmaceuticals, with the highest per capita investment in medical R&D in Europe, making it one of the world's top three "Medicine Valleys." Yoshiaki Tsukamoto, Executive Director, Japan Bioindustry Association (JBA), stated that Japan has globally leading capabilities in biotech and biopharmaceutical research. In recent years, Japan's biotech industry has placed a strong emphasis on innovation, especially in areas such as bio-pharmaceuticals, regenerative medicine, and gene editing. From Thailand, Nares Damrongchai, Co-Founder, Accel Group Co., Ltd. and former Director of the National TCELS Program, shared insights on the development of life sciences and diagnostic testing in Thailand, along with the nation's experience in international cooperation through the Asia-Pacific Economic Cooperation (APEC). Murali Panchapagesa Muthuswamy, former chairman of the Indian Biotech Industry Association, proposed collaborations between Taiwan's R&D and India's manufacturing capabilities, encouraging the use of India's production capacities for pharmaceuticals and vaccines. Representatives from all participating countries expressed a strong desire for increased cooperation in regulatory review across Asia, which would help biotech and pharmaceutical companies unlock international market opportunities. This collaboration aims to expand the scope of each country's biotech industry, fostering win-win and even multi-win situations, injecting new vitality into industry development and creating new opportunities across borders. Full Photo Albums: Plenary Session: https://lnkd.in/gUy_2mRh Belgium Session: https://lnkd.in/gxr3MU_S Japan Session: https://lnkd.in/gjECKmyC Thailand Session: https://lnkd.in/gep5Cgey India Session: https://lnkd.in/g4S5j4ys Malaysia Session: https://lnkd.in/gX56yzGi
-
-
-
-
-
+1